Home » Thought Leadership » Infographics » The UK Introduces New Access a…

The UK Introduces New Access and Licensing Pathway for Innovative Medicines

February 25, 2021


Written by: Jay Galli Esmee Scriven Nelli Morgulchik

The MHRA has publicly identified improving time to market and patient access for innovative medicines as a key ongoing initiative in the UK. To support these goals, a new Innovative Licensing and Access Pathway (ILAP) was implemented in JAN 2021 to help smooth the journey from the clinic to the market.

In this infographic, CBPartners outlines the eligibility requirements, application process and offers insightful key takeaways about the pathway.

Read the infographic here.